£1.20m
+35%vs Dec 2023Active08497840Private limited companySwansea
ARCADIA PHARMA LIMITED
Significant control: Michael John Overy (25–50%), Christopher John Colebrook (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Arcadia Pharma Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ARCADIA PHARMA LIMITED is an active private limited company (company number 08497840) incorporated on 22 April 2013, registered in Swansea. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 December 2024, showing net assets of £1.20m and cash of £295k, with 30 employees on average. Net assets rose 35% on the prior period (£892k).
Peer position · net assets
By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Mr Michael John Overy
- owns 25–50% of shares
- Mr Christopher John Colebrook
- owns 25–50% of shares
- Mr Jeffrey Raymond Albert Everett
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 April 201313 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 6 May 2027in 195 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£295k
−42%vs Dec 2023Not reported
30
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £1.20m | £295k | — | £1.31m | — | — | 30 |
| 31 December 2023 | £892k | £505k | — | £1.35m | — | — | 30 |
Current ratio2.02Current assets ÷ creditors within one year
Cash per employee£9,817Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,199,601 at 31 December 2024
- Net assets up 10% or more on the prior period+34.5% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.02
- Cash at bank of £50,000 or moreCash £294,501
- Incorporated five or more years agoIncorporated 22 April 2013
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 195 days
- Next accounts due23 days overdue
- Accounts period endNet assets £1.20m · small accounts
- Accounts period endNet assets £892k · small accounts
- Incorporated
08
Similar companies in Swansea
- AVICENNA HERBAL PRODUCTS LIMITEDLampeter · inc. Apr 2016
- SOUTH WALES SPECIALS LIMITEDLlansamlet · inc. Jun 1935
All companies incorporated on 22 April 2013 · in Apr 2013.
09
Reminders for ARCADIA PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.